The transcriptional co-repressor function of UHRF1 was illustrated in experiments conducted on glioma and mesothelioma cells, in which UHRF1 contributed to the epigenetic silencing of NY-ESO1, a cancer-testis antigen regarded as a target for cancer immunotherapy. The gene discussed is UHRF1; the disease is central nervous system cancer.